Genentech priced avastin a lot lower than the market research stated they should.
What did the market research say?
p.s. Can you imagine if Genentech had priced Avastin so the price of a single eye-sized dose after compounding pharmacists aliquot a vial was competitive with Lucentis? I’m not sure the number would fit on my calculator.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.